$ANTX
AN2 Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
AN2 Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ANTX down today? It is at $5.08 (-2.68%), and our scanner flagged it 91 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ANTX spikes, and full due diligence on ANTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ANTX 91 times in the last 30 days. Create a free account to track $ANTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how ANTX traded in the last session, Friday (last price and move above). Our scanner fired 19 unusual-volume and momentum alerts on ANTX on Friday, peaking at 44.0x its normal volume.
Likely catalystAN2 Therapeutics, Inc.: Q3 FY2026 results, three months to Sep 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedNov 16, 2026 · 5 days agoAcross every filing on file, supply equal to 871.9% of the tradeable float is in play - 871.9% more can still be issued.
Shelf sizes are dollars, so shares are estimated at today's price.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
14,035,104 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Eizen Joshua M Officer | Sold (automatic/other) | -3K | sold 1.3% | 208K | $12K at $4.22 | Nov 5, 26 |
Aziz Kabeer Director | Acquired (grant/award) | +2K | added 4.2% | 62K | n/a | Oct 12, 26 |
Martin Patricia A. Director | Acquired (grant/award) | +389 | added 2.1% | 19K | n/a | Oct 12, 26 |
Marks Gilbert Lynn Director | Acquired (grant/award) | +2K | added 2.8% | 84K | n/a | Oct 12, 26 |
Trenor Cameron C. Iii Officer | Acquired (grant/award) | +117K 0.3% of company | n/a | 117K | n/a | Sep 15, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -1K | sold <0.1% | 1.18M | $7K at $6.02 | Sep 9, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -10K 0.03% of company | sold 0.8% | 1.18M | $60K at $6.02 | Sep 8, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -6K 0.02% of company | sold 1.1% | 563K | $37K at $6.07 | Sep 3, 26 |
Fitzpatrick Margaret M Director | Bought (open market) | +2K | added 24% | 11K | $12K at $5.53 | Sep 1, 26 |
Williams Sarah Joanne Officer | Sold (automatic/other) | -272 | sold 0.4% | 66K | $2K at $5.53 | Sep 1, 26 |
Readnour Robin Shane Director | Sold (automatic/other) | -35K 0.09% of company | sold 2.9% | 1.20M | $213K at $6.01 | Aug 17, 26 |
Zakrzewski Joseph S Director | Sold (automatic/other) | -406K 1.1% of company | n/a | n/a | n/a | Aug 14, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.



The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
The market is closed. Here is how ANTX traded in the last session, Friday (last price and move above). Our scanner fired 19 unusual-volume and momentum alerts on ANTX on Friday, peaking at 44.0x its normal volume.
ANTX last traded at $5.08, down 2.68% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Yes. ANTX currently has a dividend yield of about 51.67% ($2.63 per share per year). Dividend figures can change; this is not investment advice.
The ANTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ANTX 91 times in the last 30 days.
ANTX (AN2 Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $193M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ANTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ANTX discussion
Sign in to ask a question or join the discussion.